Latest Antipsychotic Stories

Sheller, P.C. Attorney Brian J. McCormick comments on whether recent verdicts of $1.5+ billion will influence Johnson and Johnson policy and ultimately affect consumers. The firm represents children suffering serious side effects from the antipsychotic drug Risperdal, manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. Philadelphia, PA (PRWEB) May 04, 2012 “Now that insider Alex Gorsky has succeeded William Weldon as Johnson and Johnson’s Chief Executive...

48-state study lays groundwork for state-level action A few months after the federal Government Accountability Office (GAO) issued a report on the use of psychoactive drugs by children in foster care in five states, a national study from PolicyLab at The Children's Hospital of Philadelphia describes prescription patterns over time in 48 states. The updated findings show the percentage of children in foster care taking antipsychotics--a class of psychoactive drugs associated with serious...

48-state study lays groundwork for state-level action PHILADELPHIA, April 30, 2012 /PRNewswire-USNewswire/ -- A few months after the federal Government Accountability Office (GAO) issued a report on the use of psychoactive drugs by children in foster care in five states, a national study from PolicyLab at The Children's Hospital of Philadelphia describes prescription patterns over time in 48 states. The updated findings show the percentage of children in foster care taking...

PITTSBURGH, April 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg. This product is the generic version of Eli Lilly and Company's Zyprexa®, which is indicated for the treatment of schizophrenia and the acute treatment of...

Research: Early detection and intervention evaluation for people at risk of psychosis: Multisite randomized controlled trial Cognitive therapy reduces the severity of psychotic experiences in adults who are at risk of developing conditions such as schizophrenia, a randomized controlled trial published on bmj.com claims. Authors from several UK universities (Birmingham, Glasgow, Cambridge, Manchester and UEA), led by the University of Manchester, set out to determine whether cognitive...

Mouse model of anorexia offers opportunity to study drugs effective for disorder Low doses of a commonly used atypical antipsychotic drug improved survival in a mouse model of anorexia nervosa, University of Chicago researchers report this month. The result offers promise for a common and occasionally fatal eating disorder that currently lacks approved drugs for treatment. Mice treated with small doses of the drug olanzapine were more likely to maintain their weight when given an...

Among 6-month-old infants, a history of intrauterine antipsychotic medication exposure was associated with significantly lower scores on a standard test of neuromotor performance, according to a report published Online First by Archives of General Psychiatry, a JAMA Network publication. About two-thirds of women with a history of mental illness give birth. Despite the significant morbidity (illness or disease) associated with maternal mental illness during pregnancy, treatment guidelines...

PITTSBURGH, March 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg. This product is the generic version of AstraZeneca's Seroquel®, which is an atypical antipsychotic medication indicated for the treatment of schizophrenia, and for the treatment of acute manic...

Antipsychotic medication was associated with a modest and time-limited increased risk of myocardial infarction (heart attack) among older patients treated with cholinesterase inhibitors for dementia, according to a study published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals. Antipsychotic medications are commonly prescribed for older patients to manage the symptoms of dementia, which can include physical aggression, agitation and hallucinations. For...

Physicians who prescribe antipsychotic medications may be basing their decisions on incomplete information, according to new research published by scientists at Oregon Health & Science University. The study is published in PLoS Medicine, a peer-reviewed open-access journal published by the Public Library of Science. This latest research follows a highly publicized 2008 report in the New England Journal of Medicine demonstrating that antidepressant drug trials were selectively...